Bromocriptine is a sympatholytic D2-dopamine agonist that has been approved for the treatment of type 2 diabetes. Based on animal and human studies, timed bromocriptine administration within 2 h ...

Bromocriptine is unique in that it does not have a specific receptor that mediates its action on glucose and lipid metabolism. Rather, its effects are mediated via resetting of dopaminergic and ...

Medindia neither buys nor sells drugs. Bromocriptine is a dopamine agonist, prescribed for Parkinson’s disease either alone or with other medications. It is also used for galactorrhoea (abnormal ...